ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Virus Banking Service Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-34D18488
Home | Market Reports | Computers & Electronics| Computer Security
Global Virus Banking Service Market Research Report 2024
BUY CHAPTERS

Global Virus Banking Service Market Research Report 2026

Code: QYRE-Auto-34D18488
Report
2026-01-21
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck KGaA
Catalent
GenIbet
ViruSure
Recipharm
ABL, Inc.
SK pharmteco
Charles River Laboratories
Biovian
Creative Biogene
Clean Biologics

Virus Banking Service Market Size

The global Virus Banking Service market was valued at US$ 915 million in 2025 and is anticipated to reach US$ 1706 million by 2032, at a CAGR of 9.4% from 2026 to 2032.

Virus Banking Service Market

Virus Banking Service Market

Viral banks are the systematic storage and management of cell lines or viral vectors for biopharmaceutical and therapeutic development. They are often used to produce vaccines, gene therapy products, and other biological drugs.
The North American market for Virus Banking Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Virus Banking Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Virus Banking Service in Vaccine Development is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Virus Banking Service include Merck KGaA, Catalent, Inc, GenIbet, ViruSure GmbH, Recipharm AB, ABL, Inc., SK pharmteco, Charles River Laboratories, Clean Biologics, BIOVIAN, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Virus Banking Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Virus Banking Service. The Virus Banking Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Virus Banking Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Virus Banking Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Virus Banking Service Market Report

Report Metric Details
Report Name Virus Banking Service Market
Accounted market size in 2025 US$ 915 in million
Forecasted market size in 2032 US$ 1706 million
CAGR 9.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • MVSS
  • WVSS
Segment by Application
  • Vaccine Development
  • Gene Therapy
  • Bioanalysis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck KGaA, Catalent, Inc, GenIbet, ViruSure GmbH, Recipharm AB, ABL, Inc., SK pharmteco, Charles River Laboratories, Clean Biologics, BIOVIAN, Creative Biogene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Virus Banking Service companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Virus Banking Service Market growing?

Ans: The Virus Banking Service Market witnessing a CAGR of 9.4% during the forecast period 2026-2032.

What is the Virus Banking Service Market size in 2032?

Ans: The Virus Banking Service Market size in 2032 will be US$ 1706 million.

Who are the main players in the Virus Banking Service Market report?

Ans: The main players in the Virus Banking Service Market are Merck KGaA, Catalent, Inc, GenIbet, ViruSure GmbH, Recipharm AB, ABL, Inc., SK pharmteco, Charles River Laboratories, Clean Biologics, BIOVIAN, Creative Biogene

What are the Application segmentation covered in the Virus Banking Service Market report?

Ans: The Applications covered in the Virus Banking Service Market report are Vaccine Development, Gene Therapy, Bioanalysis

What are the Type segmentation covered in the Virus Banking Service Market report?

Ans: The Types covered in the Virus Banking Service Market report are MVSS, WVSS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virus Banking Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 MVSS
1.2.3 WVSS
1.3 Market by Application
1.3.1 Global Virus Banking Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Vaccine Development
1.3.3 Gene Therapy
1.3.4 Bioanalysis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Virus Banking Service Market Perspective (2021–2032)
2.2 Global Virus Banking Service Growth Trends by Region
2.2.1 Global Virus Banking Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Virus Banking Service Historic Market Size by Region (2021–2026)
2.2.3 Virus Banking Service Forecasted Market Size by Region (2027–2032)
2.3 Virus Banking Service Market Dynamics
2.3.1 Virus Banking Service Industry Trends
2.3.2 Virus Banking Service Market Drivers
2.3.3 Virus Banking Service Market Challenges
2.3.4 Virus Banking Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virus Banking Service Players by Revenue
3.1.1 Global Top Virus Banking Service Players by Revenue (2021–2026)
3.1.2 Global Virus Banking Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Virus Banking Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Virus Banking Service Revenue
3.4 Global Virus Banking Service Market Concentration Ratio
3.4.1 Global Virus Banking Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virus Banking Service Revenue in 2025
3.5 Global Key Players of Virus Banking Service Head Offices and Areas Served
3.6 Global Key Players of Virus Banking Service, Products and Applications
3.7 Global Key Players of Virus Banking Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Virus Banking Service Breakdown Data by Type
4.1 Global Virus Banking Service Historic Market Size by Type (2021–2026)
4.2 Global Virus Banking Service Forecasted Market Size by Type (2027–2032)
5 Virus Banking Service Breakdown Data by Application
5.1 Global Virus Banking Service Historic Market Size by Application (2021–2026)
5.2 Global Virus Banking Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Virus Banking Service Market Size (2021–2032)
6.2 North America Virus Banking Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Virus Banking Service Market Size by Country (2021–2026)
6.4 North America Virus Banking Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Virus Banking Service Market Size (2021–2032)
7.2 Europe Virus Banking Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Virus Banking Service Market Size by Country (2021–2026)
7.4 Europe Virus Banking Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Virus Banking Service Market Size (2021–2032)
8.2 Asia-Pacific Virus Banking Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Virus Banking Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Virus Banking Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Virus Banking Service Market Size (2021–2032)
9.2 Latin America Virus Banking Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Virus Banking Service Market Size by Country (2021–2026)
9.4 Latin America Virus Banking Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Virus Banking Service Market Size (2021–2032)
10.2 Middle East & Africa Virus Banking Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Virus Banking Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Virus Banking Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Virus Banking Service Introduction
11.1.4 Merck KGaA Revenue in Virus Banking Service Business (2021–2026)
11.1.5 Merck KGaA Recent Development
11.2 Catalent, Inc
11.2.1 Catalent, Inc Company Details
11.2.2 Catalent, Inc Business Overview
11.2.3 Catalent, Inc Virus Banking Service Introduction
11.2.4 Catalent, Inc Revenue in Virus Banking Service Business (2021–2026)
11.2.5 Catalent, Inc Recent Development
11.3 GenIbet
11.3.1 GenIbet Company Details
11.3.2 GenIbet Business Overview
11.3.3 GenIbet Virus Banking Service Introduction
11.3.4 GenIbet Revenue in Virus Banking Service Business (2021–2026)
11.3.5 GenIbet Recent Development
11.4 ViruSure GmbH
11.4.1 ViruSure GmbH Company Details
11.4.2 ViruSure GmbH Business Overview
11.4.3 ViruSure GmbH Virus Banking Service Introduction
11.4.4 ViruSure GmbH Revenue in Virus Banking Service Business (2021–2026)
11.4.5 ViruSure GmbH Recent Development
11.5 Recipharm AB
11.5.1 Recipharm AB Company Details
11.5.2 Recipharm AB Business Overview
11.5.3 Recipharm AB Virus Banking Service Introduction
11.5.4 Recipharm AB Revenue in Virus Banking Service Business (2021–2026)
11.5.5 Recipharm AB Recent Development
11.6 ABL, Inc.
11.6.1 ABL, Inc. Company Details
11.6.2 ABL, Inc. Business Overview
11.6.3 ABL, Inc. Virus Banking Service Introduction
11.6.4 ABL, Inc. Revenue in Virus Banking Service Business (2021–2026)
11.6.5 ABL, Inc. Recent Development
11.7 SK pharmteco
11.7.1 SK pharmteco Company Details
11.7.2 SK pharmteco Business Overview
11.7.3 SK pharmteco Virus Banking Service Introduction
11.7.4 SK pharmteco Revenue in Virus Banking Service Business (2021–2026)
11.7.5 SK pharmteco Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Virus Banking Service Introduction
11.8.4 Charles River Laboratories Revenue in Virus Banking Service Business (2021–2026)
11.8.5 Charles River Laboratories Recent Development
11.9 Clean Biologics
11.9.1 Clean Biologics Company Details
11.9.2 Clean Biologics Business Overview
11.9.3 Clean Biologics Virus Banking Service Introduction
11.9.4 Clean Biologics Revenue in Virus Banking Service Business (2021–2026)
11.9.5 Clean Biologics Recent Development
11.10 BIOVIAN
11.10.1 BIOVIAN Company Details
11.10.2 BIOVIAN Business Overview
11.10.3 BIOVIAN Virus Banking Service Introduction
11.10.4 BIOVIAN Revenue in Virus Banking Service Business (2021–2026)
11.10.5 BIOVIAN Recent Development
11.11 Creative Biogene
11.11.1 Creative Biogene Company Details
11.11.2 Creative Biogene Business Overview
11.11.3 Creative Biogene Virus Banking Service Introduction
11.11.4 Creative Biogene Revenue in Virus Banking Service Business (2021–2026)
11.11.5 Creative Biogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck KGaA
Catalent
GenIbet
ViruSure
Recipharm
ABL, Inc.
SK pharmteco
Charles River Laboratories
Biovian
Creative Biogene
Clean Biologics
List of Tables
 Table 1. Global Virus Banking Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of MVSS
 Table 3. Key Players of WVSS
 Table 4. Global Virus Banking Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Virus Banking Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Virus Banking Service Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Virus Banking Service Market Share by Region (2021–2026)
 Table 8. Global Virus Banking Service Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Virus Banking Service Market Share by Region (2027–2032)
 Table 10. Virus Banking Service Market Trends
 Table 11. Virus Banking Service Market Drivers
 Table 12. Virus Banking Service Market Challenges
 Table 13. Virus Banking Service Market Restraints
 Table 14. Global Virus Banking Service Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Virus Banking Service Market Share by Players (2021–2026)
 Table 16. Global Top Virus Banking Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Virus Banking Service Revenue, 2025
 Table 17. Ranking of Global Top Virus Banking Service Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Virus Banking Service Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Virus Banking Service, Headquarters and Area Served
 Table 20. Global Key Players of Virus Banking Service, Products and Applications
 Table 21. Global Key Players of Virus Banking Service, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Virus Banking Service Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Virus Banking Service Revenue Market Share by Type (2021–2026)
 Table 25. Global Virus Banking Service Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Virus Banking Service Revenue Market Share by Type (2027–2032)
 Table 27. Global Virus Banking Service Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Virus Banking Service Revenue Market Share by Application (2021–2026)
 Table 29. Global Virus Banking Service Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Virus Banking Service Revenue Market Share by Application (2027–2032)
 Table 31. North America Virus Banking Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Virus Banking Service Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Virus Banking Service Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Virus Banking Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Virus Banking Service Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Virus Banking Service Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Virus Banking Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Virus Banking Service Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Virus Banking Service Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Virus Banking Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Virus Banking Service Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Virus Banking Service Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Virus Banking Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Virus Banking Service Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Virus Banking Service Market Size by Country (US$ Million), 2027–2032
 Table 46. Merck KGaA Company Details
 Table 47. Merck KGaA Business Overview
 Table 48. Merck KGaA Virus Banking Service Product
 Table 49. Merck KGaA Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 50. Merck KGaA Recent Development
 Table 51. Catalent, Inc Company Details
 Table 52. Catalent, Inc Business Overview
 Table 53. Catalent, Inc Virus Banking Service Product
 Table 54. Catalent, Inc Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 55. Catalent, Inc Recent Development
 Table 56. GenIbet Company Details
 Table 57. GenIbet Business Overview
 Table 58. GenIbet Virus Banking Service Product
 Table 59. GenIbet Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 60. GenIbet Recent Development
 Table 61. ViruSure GmbH Company Details
 Table 62. ViruSure GmbH Business Overview
 Table 63. ViruSure GmbH Virus Banking Service Product
 Table 64. ViruSure GmbH Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 65. ViruSure GmbH Recent Development
 Table 66. Recipharm AB Company Details
 Table 67. Recipharm AB Business Overview
 Table 68. Recipharm AB Virus Banking Service Product
 Table 69. Recipharm AB Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 70. Recipharm AB Recent Development
 Table 71. ABL, Inc. Company Details
 Table 72. ABL, Inc. Business Overview
 Table 73. ABL, Inc. Virus Banking Service Product
 Table 74. ABL, Inc. Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 75. ABL, Inc. Recent Development
 Table 76. SK pharmteco Company Details
 Table 77. SK pharmteco Business Overview
 Table 78. SK pharmteco Virus Banking Service Product
 Table 79. SK pharmteco Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 80. SK pharmteco Recent Development
 Table 81. Charles River Laboratories Company Details
 Table 82. Charles River Laboratories Business Overview
 Table 83. Charles River Laboratories Virus Banking Service Product
 Table 84. Charles River Laboratories Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 85. Charles River Laboratories Recent Development
 Table 86. Clean Biologics Company Details
 Table 87. Clean Biologics Business Overview
 Table 88. Clean Biologics Virus Banking Service Product
 Table 89. Clean Biologics Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 90. Clean Biologics Recent Development
 Table 91. BIOVIAN Company Details
 Table 92. BIOVIAN Business Overview
 Table 93. BIOVIAN Virus Banking Service Product
 Table 94. BIOVIAN Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 95. BIOVIAN Recent Development
 Table 96. Creative Biogene Company Details
 Table 97. Creative Biogene Business Overview
 Table 98. Creative Biogene Virus Banking Service Product
 Table 99. Creative Biogene Revenue in Virus Banking Service Business (US$ Million), 2021–2026
 Table 100. Creative Biogene Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Virus Banking Service Picture
 Figure 2. Global Virus Banking Service Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Virus Banking Service Market Share by Type: 2025 vs 2032
 Figure 4. MVSS Features
 Figure 5. WVSS Features
 Figure 6. Global Virus Banking Service Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Virus Banking Service Market Share by Application: 2025 vs 2032
 Figure 8. Vaccine Development Case Studies
 Figure 9. Gene Therapy Case Studies
 Figure 10. Bioanalysis Case Studies
 Figure 11. Virus Banking Service Report Years Considered
 Figure 12. Global Virus Banking Service Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Virus Banking Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Virus Banking Service Market Share by Region: 2025 vs 2032
 Figure 15. Global Virus Banking Service Market Share by Players in 2025
 Figure 16. Global Virus Banking Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Virus Banking Service Revenue in 2025
 Figure 18. North America Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Virus Banking Service Market Share by Country (2021–2032)
 Figure 20. United States Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Virus Banking Service Market Share by Country (2021–2032)
 Figure 24. Germany Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Virus Banking Service Market Share by Region (2021–2032)
 Figure 32. China Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Virus Banking Service Market Share by Country (2021–2032)
 Figure 40. Mexico Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Virus Banking Service Market Share by Country (2021–2032)
 Figure 44. Israel Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Virus Banking Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Merck KGaA Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 48. Catalent, Inc Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 49. GenIbet Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 50. ViruSure GmbH Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 51. Recipharm AB Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 52. ABL, Inc. Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 53. SK pharmteco Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 54. Charles River Laboratories Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 55. Clean Biologics Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 56. BIOVIAN Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 57. Creative Biogene Revenue Growth Rate in Virus Banking Service Business (2021–2026)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Cell Banking and Storage Market Research Report 2024
Global Cell Bank Market Research Report 2024
Global Viral Vector Development and Manufacturing Services Market Research Report 2025
Global Viral Vector Manufacturing Market Research Report 2024
Global Cell Banking Outsourcing Market Insights Forecast to 2030
Global Cell Bank Creation Service Market Research Report 2024
Global Research Grade Viral Vector Packaging Service Market Research Report 2025
Viral Vector Packaging Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Viral Vector and Plasmid DNA Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Clearance Service Market Insights Forecast to 2030
Global Cell Bank Production and Storage Market Research Report 2025
Global Viral Vector Based Gene Therapy Drugs Market Research Report 2024
Global Biobanking Product Market Size Status and Forecast 2021 2027
Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024
Stem Cell Banking Storage
Global Cell Culture Service Market Research Report 2025
Global Mammalian Cell Banking Market Research Report 2025
Global Blood Bank Blood Banking Market Research Report 2024
Global GMP Cell Banking Market Research Report 2025
Stem Cell Storage Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions